Lattice Biologics Ltd. (LBLTF)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | - USD | 0.0% |
| 2022 | - USD | 0.0% |
| 2021 | - USD | 100.0% |
| 2020 | -335.87 Thousand USD | 40.51% |
| 2019 | -564.55 Thousand USD | 57.52% |
| 2018 | -1.32 Million USD | 48.68% |
| 2017 | -2.58 Million USD | 24.93% |
| 2016 | -3.44 Million USD | -131002.9% |
| 2015 | -2631.46 USD | 98.41% |
| 2014 | -165.1 Thousand USD | 17.63% |
| 2013 | -200.44 Thousand USD | 18.23% |
| 2012 | -245.11 Thousand USD | 42.8% |
| 2011 | -428.51 Thousand USD | 49.96% |
| 2010 | -856.42 Thousand USD | -1951.75% |
| 2009 | -41.74 Thousand USD | 99.81% |
| 2008 | -22.16 Million USD | -725.97% |
| 2007 | -2.68 Million USD | -109.07% |
| 2006 | -1.28 Million USD | -34.28% |
| 2005 | -955.85 Thousand USD | -45.53% |
| 2004 | -656.82 Thousand USD | 0.0% |
| 2002 | -71.71 Thousand USD | 38.39% |
| 2001 | -116.4 Thousand USD | 38.36% |
| 2000 | -188.85 Thousand USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 Q2 | - USD | 0.0% |
| 2023 FY | - USD | 0.0% |
| 2023 Q4 | - USD | 0.0% |
| 2023 Q3 | - USD | 0.0% |
| 2023 Q1 | - USD | 0.0% |
| 2022 FY | - USD | 0.0% |
| 2022 Q4 | - USD | 0.0% |
| 2021 Q3 | -25.84 Thousand USD | 93.36% |
| 2021 Q1 | -116.84 Thousand USD | -39.72% |
| 2021 Q2 | -389.41 Thousand USD | -233.28% |
| 2021 FY | - USD | 100.0% |
| 2020 Q4 | -83.62 Thousand USD | 63.2% |
| 2020 Q1 | 47.08 Thousand USD | 108.49% |
| 2020 Q2 | -72.06 Thousand USD | -253.07% |
| 2020 Q3 | -227.25 Thousand USD | -215.33% |
| 2020 FY | -335.87 Thousand USD | 40.51% |
| 2019 Q2 | 196.6 Thousand USD | 9253.09% |
| 2019 FY | -564.55 Thousand USD | 57.52% |
| 2019 Q1 | 2102.00 USD | 100.35% |
| 2019 Q3 | -208.77 Thousand USD | -206.19% |
| 2019 Q4 | -554.48 Thousand USD | -165.58% |
| 2018 FY | -1.32 Million USD | 48.68% |
| 2018 Q4 | -597.29 Thousand USD | -42.08% |
| 2018 Q3 | -420.39 Thousand USD | -138.87% |
| 2018 Q2 | -175.99 Thousand USD | -29.95% |
| 2018 Q1 | -135.43 Thousand USD | 81.46% |
| 2017 Q2 | -757.04 Thousand USD | -20.5% |
| 2017 Q1 | -628.22 Thousand USD | 32.73% |
| 2017 FY | -2.58 Million USD | 24.93% |
| 2017 Q4 | -730.28 Thousand USD | -53.96% |
| 2017 Q3 | -474.34 Thousand USD | 37.34% |
| 2016 Q1 | -759.01 Thousand USD | -663.18% |
| 2016 Q4 | -933.92 Thousand USD | -17.59% |
| 2016 FY | -3.44 Million USD | -131002.9% |
| 2016 Q3 | -794.2 Thousand USD | 17.51% |
| 2016 Q2 | -962.77 Thousand USD | -26.85% |
| 2015 Q4 | -99.45 Thousand USD | -314.89% |
| 2015 Q1 | -60.37 Thousand USD | -79.91% |
| 2015 Q3 | -23.97 Thousand USD | 33.63% |
| 2015 FY | -2631.46 USD | 98.41% |
| 2015 Q2 | -36.11 Thousand USD | 40.18% |
| 2014 Q3 | -31.38 Thousand USD | 24.52% |
| 2014 FY | -165.1 Thousand USD | 17.63% |
| 2014 Q1 | -68 Thousand USD | -66.69% |
| 2014 Q2 | -41.57 Thousand USD | 38.86% |
| 2014 Q4 | -33.55 Thousand USD | -6.94% |
| 2013 Q3 | -53.08 Thousand USD | -39.5% |
| 2013 Q2 | -38.05 Thousand USD | -484.54% |
| 2013 Q4 | -40.79 Thousand USD | 23.15% |
| 2013 Q1 | -6510.21 USD | 90.84% |
| 2013 FY | -200.44 Thousand USD | 18.23% |
| 2012 FY | -245.11 Thousand USD | 42.8% |
| 2012 Q4 | -71.03 Thousand USD | 24.31% |
| 2012 Q3 | -93.84 Thousand USD | -34.64% |
| 2012 Q2 | -69.69 Thousand USD | 99.45% |
| 2012 Q1 | -12.73 Million USD | -201.61% |
| 2011 Q1 | -252.61 Thousand USD | -13.31% |
| 2011 Q2 | -145.22 Thousand USD | 42.51% |
| 2011 FY | -428.51 Thousand USD | 49.96% |
| 2011 Q4 | 12.53 Million USD | 13260.82% |
| 2011 Q3 | -95.21 Thousand USD | 34.44% |
| 2010 Q4 | -222.95 Thousand USD | -64.53% |
| 2010 FY | -856.42 Thousand USD | -1951.75% |
| 2010 Q2 | -245.36 Thousand USD | -210.82% |
| 2010 Q3 | -135.5 Thousand USD | 44.77% |
| 2010 Q1 | 221.39 Thousand USD | 149.87% |
| 2009 FY | -41.74 Thousand USD | 99.81% |
| 2009 Q1 | -22.57 Million USD | -518.04% |
| 2009 Q2 | -427.97 Thousand USD | 98.1% |
| 2009 Q3 | 455.07 Thousand USD | 206.33% |
| 2009 Q4 | -443.97 Thousand USD | -197.56% |
| 2008 FY | -22.16 Million USD | -725.97% |
| 2008 Q4 | -3.65 Million USD | -376.54% |
| 2008 Q1 | -658.22 Thousand USD | 11.86% |
| 2008 Q3 | -766.53 Thousand USD | -4.02% |
| 2008 Q2 | -736.88 Thousand USD | -11.95% |
| 2007 Q1 | -491.06 Thousand USD | -159.51% |
| 2007 FY | -2.68 Million USD | -109.07% |
| 2007 Q3 | -475.94 Thousand USD | 28.55% |
| 2007 Q4 | -746.77 Thousand USD | -56.9% |
| 2007 Q2 | -666.08 Thousand USD | -35.64% |
| 2006 FY | -1.28 Million USD | -34.28% |
| 2006 Q1 | -481.56 Thousand USD | -257.54% |
| 2006 Q2 | -275.01 Thousand USD | 42.89% |
| 2006 Q3 | -316.75 Thousand USD | -15.17% |
| 2006 Q4 | -189.22 Thousand USD | 40.26% |
| 2005 FY | -955.85 Thousand USD | -45.53% |
| 2005 Q2 | -240.41 Thousand USD | -7.1% |
| 2005 Q3 | -79.8 Thousand USD | 66.81% |
| 2005 Q4 | -134.68 Thousand USD | -68.77% |
| 2005 Q1 | -224.48 Thousand USD | -79.7% |
| 2004 Q3 | -215.4 Thousand USD | -180.93% |
| 2004 Q2 | -76.67 Thousand USD | 50.99% |
| 2004 Q1 | -156.44 Thousand USD | -176.23% |
| 2004 Q4 | -124.92 Thousand USD | 42.01% |
| 2004 FY | -656.82 Thousand USD | 0.0% |
| 2003 Q1 | -11.83 Thousand USD | 35.52% |
| 2003 Q4 | -56.63 Thousand USD | -104.54% |
| 2003 Q2 | -21.76 Thousand USD | -83.93% |
| 2003 Q3 | -27.68 Thousand USD | -27.19% |
| 2002 Q3 | -20.34 Thousand USD | 57.78% |
| 2002 Q4 | -18.35 Thousand USD | 9.8% |
| 2002 Q1 | -20.7 Thousand USD | 23.64% |
| 2002 Q2 | -48.19 Thousand USD | -132.79% |
| 2002 FY | -71.71 Thousand USD | 38.39% |
| 2001 FY | -116.4 Thousand USD | 38.36% |
| 2001 Q3 | -21.71 Thousand USD | 0.0% |
| 2001 Q4 | -27.11 Thousand USD | -24.83% |
| 2000 FY | -188.85 Thousand USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| CVR Medical Corp. | - USD | NaN% |
| BioElectronics Corporation | -274.29 Thousand USD | 100.0% |
| IR-Med Inc. | -4.91 Million USD | 100.0% |
| Polarean Imaging plc | -12.55 Million USD | 100.0% |
| Medical Supply International USA, Inc. | 438.18 Thousand USD | 100.0% |
| Avitar, Inc. | 2.73 Million USD | 100.0% |
| AVITA Medical, Inc. | -40.4 Million USD | 100.0% |
| Manhattan Scientifics, Inc. | -703 Thousand USD | 100.0% |
| Össur hf. | 87.46 Million USD | 100.0% |
| Zecotek Photonics Inc. | -3.65 Million USD | 100.0% |
| QHSLab, Inc. | -240.15 Thousand USD | 100.0% |
| Wellstar International, Inc. | -1.79 Million USD | 100.0% |
| Össur hf. | 87.46 Million USD | 100.0% |
| Bionovate Technologies Corp | - USD | NaN% |
| EKF Diagnostics Holdings plc | 2.08 Million USD | 100.0% |
| Escalon Medical Corp. | -104.47 Thousand USD | 100.0% |
| Aurora Spine Corporation | -446.19 Thousand USD | 100.0% |
| BrainsWay Ltd. | -4.92 Million USD | 100.0% |
| NewCardio, Inc. | -9.45 Million USD | 100.0% |
| Hamilton Thorne Ltd. | 277.99 Thousand USD | 100.0% |
| Vivos Inc. | -2.79 Million USD | 100.0% |
| MicroPort Scientific Corporation | -516.16 Million USD | 100.0% |
| Kelyniam Global, Inc. | -239.16 Thousand USD | 100.0% |
| REMSleep Holdings, Inc. | -1.77 Million USD | 100.0% |
| CYduct Diagnostics, Inc. | -378.9 Thousand USD | 100.0% |
| Nanomix Corporation | -8.43 Million USD | 100.0% |
| Theraclion SA | -3.48 Million USD | 100.0% |
| Lifeline Biotechnologies, Inc. | - USD | NaN% |
| Wellness Center USA, Inc. | -707.02 Thousand USD | 100.0% |
| Positron Corporation | -1.36 Million USD | 100.0% |
| Rafina Innovations Inc. | - USD | NaN% |
| Electromedical Technologies, Inc. | -2.06 Million USD | 100.0% |
| Lombard Medical, Inc. | -29.33 Million USD | 100.0% |
| ALR Technologies Inc. | -2.94 Million USD | 100.0% |
| Stratec SE | 25.26 Million USD | 100.0% |
| Vycor Medical, Inc. | 40.19 Thousand USD | 100.0% |
| Heart Tronics, Inc. | 14.46 Million USD | 100.0% |
| Nu-Med Plus, Inc. | -120.52 Thousand USD | 100.0% |
| Perimeter Medical Imaging AI, Inc. | -20.72 Million USD | 100.0% |
| SANUWAVE Health, Inc. | -540 Thousand USD | 100.0% |
| VMS Rehab Systems, Inc. | -68.66 USD | 100.0% |
| Guided Therapeutics, Inc. | -3.45 Million USD | 100.0% |
| Ingen Technologies, Inc. | -1.61 Million USD | 100.0% |
| Odyssey Group International, Inc. | 14.26 Million USD | 100.0% |
| United American Healthcare Corporation | -67 Thousand USD | 100.0% |
| ECGI Holdings, Inc. | -407.48 Thousand USD | 100.0% |
| Capital Group Holdings, Inc. | -634.68 Thousand USD | 100.0% |
| ADM Tronics Unlimited, Inc. | -601.52 Thousand USD | 100.0% |
| Urologix, Inc. | -6.93 Million USD | 100.0% |
| Rapid Therapeutic Science Laboratories, Inc. | -1.26 Million USD | 100.0% |
| Nexeon MedSystems Inc. | -6.26 Million USD | 100.0% |
| SS Innovations International, Inc. | -20.66 Million USD | 100.0% |
| Qualis Innovations, Inc. | -230.24 Thousand USD | 100.0% |
| Smith & Nephew plc | 425 Million USD | 100.0% |
| NIOX Group Plc | 4.6 Million USD | 100.0% |
| Fuse Medical, Inc. | 383.82 Thousand USD | 100.0% |
| Broncus Holding Corporation | -33.22 Million USD | 100.0% |
| Brain Scientific Inc. | -9.6 Million USD | 100.0% |
| Pressure BioSciences, Inc. | -9.5 Million USD | 100.0% |
| Health Logic Interactive Inc. | -60.69 Thousand USD | 100.0% |